The Intersection of Cutting-Edge Social Behavioral and Biomedical Strategies for

尖端社会行为和生物医学策略的交叉点

• 批准号: 7469583
• 负责人: Mary Jane Rotheram-Borus
• 金额: $ 7.28万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-15 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7469583
• 关键词: AIDS prevention; Address; Adoption; Area; Behavior Therapy; Behavioral; Behavioral Research; Biomedical Technology; Caring; Commit; Communities; Ensure; Government Officials; HIV; Intervention; Intervention Studies; Manuscripts; Monograph; Outcome; Participant; Peer Review; Policy Maker; Prevention; Prevention approach; Prevention strategy; Request for Proposals; Research; Research Personnel; Role; Series; Services; Technology; Update; Workplace; digital; novel; social; success; symposium; transmission process; uptake

DESCRIPTION (provided by applicant): Emerging biomedical approaches to HIV prevention can leverage the successes of behavioral interventions in curtailing HIV transmission. However, implementation of these biomedical approaches will generate a new set of behavioral research and implementation challenges. These issues must be addressed to ensure that the full benefit of an expanded biomedical and behavioral prevention portfolio is realized. The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) is committed to a behavioral intervention research agenda in three broad areas: 1) biomedical technologies for HIV prevention; 2) strategies for adaptation and adoption of efficacious interventions; and 3) the application of digital technology to deliver HIV prevention and care interventions. This R-13 proposal requests support to advance the Center's first and second areas of its behavioral-intervention research agenda through a conference series to stimulate and facilitate further research on the role of social and behavioral research in the acceptability, sustainability, adoption, and implementation of new biomedical strategies for HIV prevention throughout the world. The objectives of the proposed conference series are: 1) to host an interactive set of working meetings to explore the intersection of social, behavioral, and biomedical strategies in advancing novel HIV prevention strategies globally; 2) to outline a research agenda for developing, mounting, and sustaining social and behavioral strategies to increase uptake of new biomedical approaches to HIV prevention; 3) to establish new biomedical and behavioral research partnerships to operationalize the research agenda; and, 4) to generate monographs and peer-reviewed manuscripts that document key issues regarding the role of social and behavioral research in the acceptability, sustainability, adoption, and implementation of new biomedical strategies for HIV prevention worldwide. The following will be the three primary outcomes from each conference: 1) monograph summarizing research agenda for developing, mounting, and sustaining social and behavioral strategies to increase the update of the new biomedical prevention approach; 2) a commissioned peer-reviewed manuscript that outlines key issues raised during the conference; and, 3) creation of new biomedical and behavioral research partnerships to begin to operationalize the research agenda articulated at each conference. Conference participants will include: biomedical and behavioral investigators; government officials; U.S. and other nation's policy makers; and community representatives.

描述（由申请人提供）：新兴的生物医学方法可以利用行为干预的成功来减少艾滋病毒的传播。然而，这些生物医学方法的实施将产生一系列新的行为研究和实施挑战。必须解决这些问题，以确保扩大生物医学和行为预防组合的全部好处得以实现。艾滋病毒识别、预防和治疗服务中心（CHIPTS）致力于三个广泛领域的行为干预研究议程：1)艾滋病毒预防的生物医学技术；2)适应和采用有效干预措施的战略；3)应用数字技术提供艾滋病毒预防和护理干预措施。这项R-13提案要求支持通过一系列会议来推进该中心行为干预研究议程的第一和第二领域，以刺激和促进进一步研究社会和行为研究在全球范围内预防艾滋病毒的新生物医学战略的可接受性、可持续性、采用和实施方面的作用。提议的会议系列的目标是：1)举办一系列互动的工作会议，探讨社会、行为和生物医学策略在全球推进新型艾滋病毒预防策略方面的交集；2)概述一项研究议程，以制定、建立和维持社会和行为战略，以增加采用新的生物医学方法来预防艾滋病毒；3)建立新的生物医学和行为研究伙伴关系，以实施研究议程；4)撰写专著和同行评议的手稿，记录有关社会和行为研究在全球范围内预防艾滋病毒的新生物医学策略的可接受性、可持续性、采用和实施中的作用的关键问题。以下将是每次会议的三个主要成果：1)总结研究议程的专著，以制定，建立和维持社会和行为策略，以增加新的生物医学预防方法的更新；2)委托同行评审的手稿，概述会议期间提出的关键问题；3)建立新的生物医学和行为研究伙伴关系，开始实施每次会议上阐述的研究议程。与会者包括：生物医学和行为研究者；政府官员;美国和其他国家的决策者；还有社区代表。